Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1B1 | Q16678 | 4/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
| ▸ | ESR1 | P03372 | 1/20 | 0.31 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10015430 | 1.00 | CYP1B1 (0.33) | CYP1B1CYP1A2CYP3A4CYP2C9CYP2C19 | |
| SCHEMBL4975722 | 0.89 | CYP1A2 (0.35) | CYP1B1CYP1A2CYP3A4CYP2C9CYP2C19 | |
| SCHEMBL14727348 | 0.87 | CYP1B1 (0.32) | CYP1B1CYP1A2CYP3A4CYP2C9CYP2C19 | |
| SCHEMBL4885763 | 0.87 | CYP1A2 (0.40) | CYP1B1CYP1A2CYP3A4CYP2C9CYP2C19 | |
| SCHEMBL4886531 | 0.87 | CYP1A2 (0.40) | CYP1B1CYP1A2CYP3A4CYP2C9CYP2C19 | |
| SCHEMBL11954581 | 0.86 | CYP1A2 (0.35) | CYP1B1CYP1A2MAPK1 | |
| SCHEMBL3437824 | 0.86 | CYP1A2 (0.37) | CYP1B1CYP1A2CYP3A4CYP2C9CYP2C19 | |
| SCHEMBL21699093 | 0.86 | CYP1A2 (0.37) | CYP1B1CYP1A2CYP3A4CYP2C9CYP2C19 | |
| SCHEMBL14262642 | 0.84 | CYP1A2 (0.37) | CYP1B1CYP1A2CYP3A4CYP2C9CYP2C19 | |
| SCHEMBL13090418 | 0.83 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3422431-B1 | ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO (JP) | 2021-11-03 | — | — | EP | disclosed |
| US-9461260-B2 | Organic light emitting device | CANON KABUSHIKI KAISHA (JP) | 2016-10-04 | — | — | US | disclosed |
| US-9461260-B2 | Organic light emitting device | CANON KABUSHIKI KAISHA (JP) | 2016-10-04 | — | — | US | disclosed |
| US-9315460-B2 | Organic compound, light-emitting device, and image display apparatus | CANON KABUSHIKI KAISHA (JP) | 2016-04-19 | — | — | US | disclosed |
| US-9315460-B2 | Organic compound, light-emitting device, and image display apparatus | CANON KABUSHIKI KAISHA (JP) | 2016-04-19 | — | — | US | disclosed |
| US-9240554-B2 | Organic compound, organic electroluminescence element, and image display device | CANON KABUSHIKI KAISHA (JP) | 2016-01-19 | — | — | US | disclosed |
| US-9240554-B2 | Organic compound, organic electroluminescence element, and image display device | CANON KABUSHIKI KAISHA (JP) | 2016-01-19 | — | — | US | disclosed |
| EP-2421809-B1 | NOVEL ORGANIC COMPOUND, LIGHT-EMITTING DEVICE, AND IMAGE DISPLAY APPARATUS | CANON KK (JP) | 2015-09-02 | — | — | EP | disclosed |
| US-8952873-B2 | Fused polycyclic compound and organic light-emitting device using the compound | CANON KABUSHIKI KAISHA (JP) | 2015-02-10 | — | — | US | disclosed |
| US-8952873-B2 | Fused polycyclic compound and organic light-emitting device using the compound | CANON KABUSHIKI KAISHA (JP) | 2015-02-10 | — | — | US | disclosed |
| US-20130300638-A1 | ORGANIC COMPOUND, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND IMAGE DISPLAY DEVICE | CANON KABUSHIKI KAISHA (JP) | 2013-11-14 | — | — | US | disclosed |
| US-20130264550-A1 | ORGANIC LIGHT EMITTING DEVICE | CANON KABUSHIKI KAISHA (JP) | 2013-10-10 | — | — | US | disclosed |
| US-20130264550-A1 | ORGANIC LIGHT EMITTING DEVICE | CANON KABUSHIKI KAISHA (JP) | 2013-10-10 | — | — | US | disclosed |
| US-20120306727-A1 | FUSED POLYCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE USING THE COMPOUND | CANON KABUSHIKI KAISHA (JP) | 2012-12-06 | — | — | US | disclosed |
| US-20120306727-A1 | FUSED POLYCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE USING THE COMPOUND | CANON KABUSHIKI KAISHA (JP) | 2012-12-06 | — | — | US | disclosed |
| EP-2530071-A1 | Fused polycyclic compound and organic light-emitting device using the compound | Canon Kabushiki Kaisha (JP) | 2012-12-05 | — | — | EP | disclosed |
| WO-2012098793-A1 | ORGANIC COMPOUND, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND IMAGE DISPLAY DEVICE | CANON KABUSHIKI KAISHA (JP) | 2012-07-26 | — | — | WO | disclosed |
| US-20120025183-A1 | NOVEL ORGANIC COMPOUND, LIGHT-EMITTING DEVICE, AND IMAGE DISPLAY APPARATUS | CANON KABUSHIKI KAISHA (JP) | 2012-02-02 | — | — | US | disclosed |
| US-20120025183-A1 | NOVEL ORGANIC COMPOUND, LIGHT-EMITTING DEVICE, AND IMAGE DISPLAY APPARATUS | CANON KABUSHIKI KAISHA (JP) | 2012-02-02 | — | — | US | disclosed |
| WO-2010123153-A1 | NOVEL ORGANIC COMPOUND, LIGHT-EMITTING DEVICE, AND IMAGE DISPLAY APPARATUS | CANON KABUSHIKI KAISHA (JP) | 2010-10-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120025183-A1 | NOVEL ORGANIC COMPOUND, LIGHT-EMITTING DEVICE, AND IMAGE DISPLAY APPARATUS | ACE, ACE2, AGTR1 | CYP1B1 99/4885CYP1A2 182/4885CYP3A4 294/4885 |
| US-20120306727-A1 | FUSED POLYCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE USING THE COMPOUND | PPOX, INTS9, LAGE3 | CYP1B1 81/4885CYP1A2 194/4885CYP3A4 143/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.